Next Article in Journal
Therapeutic Approaches to Target Cancer Stem Cells
Next Article in Special Issue
High Resolution Fluorescence Imaging of Cancers Using Lanthanide Ion-Doped Upconverting Nanocrystals
Previous Article in Journal
Aberrant Signaling Pathways in Glioma
Previous Article in Special Issue
Gold Nanostructures as a Platform for Combinational Therapy in Future Cancer Therapeutics
Open AccessReview

Assessment of the Evolution of Cancer Treatment Therapies

Instituto de Nanociencia de Aragón (INA), Mariano Esquillor, Edif. I+D, University of Zaragoza, Zaragoza 50018, Spain
CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza 50018, Spain
Hospital Universitario La Paz-IdiPAZ, Paseo de la Castellana 261, Madrid 28046, Spain
Servicio de Oncología Médica, Hospital Clínico Universitario Lozano Blesa, Avda. San Juan Bosco 50009, Zaragoza, Spain
Instituto Aragonés de Ciencias de la Salud (I+CS), Avda. Gómez Laguna, 25, Zaragoza 50009, Spain
Lonza Biologics Porriño, A relva s/n, Porriño (Pontevedra) 36410, Spain
Immunology Deapartment, Biomedical Research Center (CINBIO), University of Vigo, Campus Lagoas Marcosende, Vigo (Pontevedra) 36310, Spain
Author to whom correspondence should be addressed.
Cancers 2011, 3(3), 3279-3330;
Received: 16 June 2011 / Revised: 7 July 2011 / Accepted: 8 August 2011 / Published: 12 August 2011
(This article belongs to the Special Issue Nanotechnology and Cancer Therapeutics)
Cancer therapy has been characterized throughout history by ups and downs, not only due to the ineffectiveness of treatments and side effects, but also by hope and the reality of complete remission and cure in many cases. Within the therapeutic arsenal, alongside surgery in the case of solid tumors, are the antitumor drugs and radiation that have been the treatment of choice in some instances. In recent years, immunotherapy has become an important therapeutic alternative, and is now the first choice in many cases. Nanotechnology has recently arrived on the scene, offering nanostructures as new therapeutic alternatives for controlled drug delivery, for combining imaging and treatment, applying hyperthermia, and providing directed target therapy, among others. These therapies can be applied either alone or in combination with other components (antibodies, peptides, folic acid, etc.). In addition, gene therapy is also offering promising new methods for treatment. Here, we present a review of the evolution of cancer treatments, starting with chemotherapy, surgery, radiation and immunotherapy, and moving on to the most promising cutting-edge therapies (gene therapy and nanomedicine). We offer an historical point of view that covers the arrival of these therapies to clinical practice and the market, and the promises and challenges they present. View Full-Text
Keywords: cancer; immunotherapy; nanotechnology; gene therapy; nanomedicine cancer; immunotherapy; nanotechnology; gene therapy; nanomedicine
Show Figures

Graphical abstract

MDPI and ACS Style

Arruebo, M.; Vilaboa, N.; Sáez-Gutierrez, B.; Lambea, J.; Tres, A.; Valladares, M.; González-Fernández, Á. Assessment of the Evolution of Cancer Treatment Therapies. Cancers 2011, 3, 3279-3330.

AMA Style

Arruebo M, Vilaboa N, Sáez-Gutierrez B, Lambea J, Tres A, Valladares M, González-Fernández Á. Assessment of the Evolution of Cancer Treatment Therapies. Cancers. 2011; 3(3):3279-3330.

Chicago/Turabian Style

Arruebo, Manuel; Vilaboa, Nuria; Sáez-Gutierrez, Berta; Lambea, Julio; Tres, Alejandro; Valladares, Mónica; González-Fernández, África. 2011. "Assessment of the Evolution of Cancer Treatment Therapies" Cancers 3, no. 3: 3279-3330.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop